A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and difficult-to-treat form of lung cancer. The study shows that a combination of two well-studied classes of drugs—ERBB…
Continue Reading
News Source: medicalxpress.com
Leave a Reply